Women's Health

The symptom of HMB may be present in up to 50% of reproductive-aged girls and women, most of whom may not even realize that what they are experiencing is abnormal.

The US FDA approved zuranolone 50 mg as the first oral, once-daily treatment for postpartum depression in adults.

A daily dose of clinical news on Patient Care you may have missed.

A daily dose of clinical news you may have missed.

A daily dose of clinical news you may have missed.

Investigators identified 6 blood pressure patterns that, when combined with other risk factors, accurately stratified risk of hypertensive disorders of pregnancy.

Total perioperative dosage of opioids was higher for abdominal vs laparoscopic hysterectomy, but procedure route was not associated with risk for long-term opioid use.

Is BMI or body fat a better estimate of obesity?; spoiler: older women do drink ETOH; USPSTF vs ACC/AHA; plus no more opioids for LBP and a primer on migraine meds.

The US FDA approved norgestrel as the first daily oral contraceptive to be available over the counter, without a prescription.

Binge drinking among women going through menopause has been on the rise, research indicates, making clinical inquiry in this population particularly important.

The greatest increase over the 10 years was seen in deaths among American Indian and Alaska Native women, according to Institute for Health Metrics and Evaluation data.

Your daily dose of clinical news you may have missed.

Higher scores on a healthy lifestyle index were associated with significantly reduced risk of incident CVD among women aged 50-79 years with BMI between 18.5 and 25.0.

Your daily dose of clinical news you may have missed.

ENDO 2023. Women with PCOS face an increased risk of mortality, particularly death due to cardiovascular disease and diabetes, compared with those without PCOS.

Ozempic impact on patients, clinicians; bempedoic acid comparable to statins; hypertension risk upped with oral estrogen HT; and 2 more quotes of note.

Your daily dose of clinical news you may have missed.

Oral estrogen hormone therapy was more likely to result in incident hypertension than transdermal or vaginal formulations in this large prospective population-based study.

Menstrual migraine is often described as more disabling than non-menstrual migraine. Get an overview and test your knowledge, here.

Your daily dose of clinical news you may have missed.

A nationally recognized obesity expert discusses mental health in women with obesity.

The findings contradict published clinical guidelines that warn against use of estrogen-containing birth control by women who have migraine with aura.

Your daily dose of clinical news you may have missed.

Women's Health Week (May 14-20, 2023) is an ideal opportunity to review the top research, policy shifts, and potential drug approvals that affect your patient panel.

Fezolinetant is the first NK3 receptor antagonist approved by the FDA for treatment of moderate-to-severe vasomotor symptoms due to menopause.